CELLASTRA INC
DELIVERING THE GENETIC CODE TO THE WOUND FOR SCAR-LESS HEALING
TARGETING GLOBAL UNMET NEEDS IN SURGERY, TRAUMA AND BURN INJURIES
CELLASTRA NEWS
CELLASTRA'S STRATEGIC REPORT 03 /11/2020:
TOP GENE THERAPY COMPANIES
CELLASTRA INC 03/03/2020
Cellastra announces long-term results from in-vivo transgene expression of proprietary anti-scarring peptide
Preparing for clinical study in burn injuries
San Francisco, CA, March 3, 2020 Cellastra, Inc., a developer of novel cell and gene therapy assets, announced today that the company has obtained promising results for CELLEXA, a proprietary gene vector enabling in-vivo production of a potent anti-scarring peptide.
Cellastra recently reported results demonstrating that CELLEXA delivers the genetic code for the lactoferrin sub-peptide with the same amino acid sequence enabling expression during the first month of ovservation.
“Our new results from long-term follow up demonstrates continued robust and durable transgenic expression and production of the peptide throughout the 11 week observation period after intramuscular injection, and furthermore no adverse effects were noted” said Dr Karl Mettinger, MD, PhD, President & CEO of C
02/19/2020
NEW GENE THERAPY INSTITUTE CREATE BY NIH
INVESTOR PRESENTATION MARCH 2020 LINK
Cellastra announces results from in-vivo transgene expression of proprietary anti-scarring peptide.
Preparing for clinical study in burn injuries
San Francisco, CA, December 15, 2019 Cellastra, Inc., a developer of novel cell and gene therapy assets, announced today that the company has obtained promising results for CELLEXA, a proprietary gene vector enabling in-vivo production of a potent anti-scarring peptide.
CELLASTRA INC 07/15/2019
Cellastra announces filing of global patent application for prevention of scars and adhesions.
CELLASTRA INC 06/24/2019
Cellastra announces collaboration with leading academic laboratory in Canada for manufacturing and testing of a novel gene vector programmed for scar prevention.
Preparing for clinical study in burn injuries
CELLASTRA INC 04/04/2019
Cellastra announces updates from American Burn Association's Annual Meeting in Las Vegas, April 2-5, 2019
Prof. Folke Sjoberg, Cellastra Scientific Advisory Board Memberawarded to give the Everett Idris Evans Memorial Lecture on frontiers in burn injury treatment
Cellastra prepares for clinical study in burn injury
